18th International Congress on Infectious Diseases

1st to 4th March 2018, Buenos Aires, Argentina.

The International Society for Infectious Diseases will hold its next International Congress on Infectious Diseases (ICID) in Buenos Aires, Argentina from the 1st to the 4th of March 2018. The meeting will be held in conjunction with the XVIII Congreso de la Sociedad Argentina de Infectología (SADI, the Infectious Diseases Society of Argentina) with the two societies collaborating to offer what will be an outstanding program of both regional and international expertise.

The 18th ICID will encompass all of the fields of infectious diseases with particular attention being paid to the major challenges of the region including, of course, Zika, dengue and other related viral infections, AIDS, tuberculosis, pneumonia, and enteric and parasitic infections. ISID has been at the forefront of the One Health movement and this is reflected in our meetings, which also have a major focus on disease prevention and vaccine implementation.

ISID meetings are distinguished by their unique blend of basic science and clinical practice. With state-of-the-art scientific presentations delivered by a global faculty with first-hand experience and knowledge of the conditions that they discuss, ISID meetings are notable for the extraordinarily wide range of countries represented and the opportunity they offer for close exchange and communication between senior and junior colleagues.

General Information
Date: 1st to 4th March 2018

Location:
Sheraton Buenos Aires
San Martin 1225/1275
1104 Buenos Aires
Argentina

Programme: Find the preliminary scientific programme here.

Registration: For more information on registration and fees click here.

Find more information on the congress congress website.


Published in GI-Mail 11/2017 (English edition). Sign up for GI-Mail here.  

Tip: More up to date educational events can be found online in the Education Database »medicine & health«.

    Bildungs-Newsletter

    Job-Newsletter

    Archive

    Comments are closed.